Progenity Inc
NASDAQ:PROG
Progenity Inc
Free Cash Flow
Progenity Inc
Free Cash Flow Peer Comparison
Competitive Free Cash Flow Analysis
Latest Figures & CAGR of Competitors
Company | Free Cash Flow | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Progenity Inc
NASDAQ:PROG
|
Free Cash Flow
-$168.3m
|
CAGR 3-Years
-34%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
DaVita Inc
NYSE:DVA
|
Free Cash Flow
$920.3m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
29%
|
CAGR 10-Years
-3%
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Free Cash Flow
$947m
|
CAGR 3-Years
-23%
|
CAGR 5-Years
0%
|
CAGR 10-Years
7%
|
|
CVS Health Corp
NYSE:CVS
|
Free Cash Flow
$8.1B
|
CAGR 3-Years
-14%
|
CAGR 5-Years
6%
|
CAGR 10-Years
7%
|
|
Cigna Corp
NYSE:CI
|
Free Cash Flow
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Free Cash Flow
$683.2m
|
CAGR 3-Years
-37%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
2%
|
See Also
What is Progenity Inc's Free Cash Flow?
Free Cash Flow
-168.3m
USD
Based on the financial report for Dec 31, 2021, Progenity Inc's Free Cash Flow amounts to -168.3m USD.
What is Progenity Inc's Free Cash Flow growth rate?
Free Cash Flow CAGR 3Y
-34%
Over the last year, the Free Cash Flow growth was 1%. The average annual Free Cash Flow growth rates for Progenity Inc have been -34% over the past three years .